Sign in
4

Changes in Ownership

Kiniksa Pharmaceuticals International, plc Filed Acc 0001415889-25-021941

Director sold 177,769 shares at an average $32.96 ($5,859,815)

  • Director acquired 177,769 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Malley Thomas Director 2025-08-12 Option exercise +21,959 $1.86 $40,844 34,505 D
Malley Thomas Director 2025-08-12 Option exercise +27,448 $3.80 $104,302 61,953 D
Malley Thomas Director 2025-08-12 Sale −49,407 $32.40 $1,600,787 12,546 D
Malley Thomas Director 2025-08-13 Option exercise +20,129 $10.36 $208,536 32,675 D
Malley Thomas Director 2025-08-13 Option exercise +30,000 $9.88 $296,400 62,675 D
Malley Thomas Director 2025-08-13 Sale −50,129 $33.32 $1,670,298 12,546 D
Malley Thomas Director 2025-08-14 Option exercise +18,760 $15.47 $290,217 31,306 D
Malley Thomas Director 2025-08-14 Option exercise +33,237 $14.33 $476,286 64,543 D
Malley Thomas Director 2025-08-14 Option exercise +26,236 $15.19 $398,525 90,779 D
Malley Thomas Director 2025-08-14 Sale −78,233 $33.09 $2,588,730 12,546 D
Derivatives
Malley Thomas Director 2025-08-12 Option exercise · Share Option −21,959 0 D
Malley Thomas Director 2025-08-12 Option exercise · Share Option −27,448 0 D
Malley Thomas Director 2025-08-13 Option exercise · Share Option −20,129 0 D
Malley Thomas Director 2025-08-13 Option exercise · Share Option −30,000 0 D
Malley Thomas Director 2025-08-14 Option exercise · Share Option −18,760 0 D
Malley Thomas Director 2025-08-14 Option exercise · Share Option −33,237 0 D
Malley Thomas Director 2025-08-14 Option exercise · Share Option −26,236 0 D
Open-market sales · 177,769 sh · avg $32.96 · $5,859,815
Loading xslF345X05/form4-08142025_080859.xml…